" /> E1-INT - CISMeF





Preferred Label : E1-INT;

MeSH note : an injectable islet neogenesis therapy comprising an epidermal growth factor analog and a gastrin analog, for the treatment of insulin-dependent (type 1) and non-insulin-dependent (type 2) diabetes; Hypoglycemic Agents;

Is substance : O;

Details


You can consult :


Nous contacter.
18/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.